Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes

Inflammation

Volumn 37, Issue 3, 2014, Pages 893-907

  Nyagode, Beatrice A ^a   Williams, Ifor R ^a   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute phase proteins; C. rodentium; Cyp4a; fatty acids; LPS

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA FIBRINOGEN; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; CYTOCHROME P450 4A; FIBRINOGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OROSOMUCOID; SERUM AMYLOID P; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYP4A10 PROTEIN, MOUSE; CYP4A14 PROTEIN, MOUSE; CYTOCHROME P450; CYTOKINE; LIPOPOLYSACCHARIDE; SODIUM INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CITROBACTER RODENTIUM; CONTROLLED STUDY; CYP4A10 GENE; CYP4A14 GENE; CYTOKINE RESPONSE; ENTEROBACTERIACEAE INFECTION; FEMALE; GENE; GENE DELETION; GENOTYPE; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; INTESTINE CRYPT; LIVER DISEASE; MALE; MOUSE; NONHUMAN; SODIUM INTAKE; SODIUM RESTRICTION; SPLEEN WEIGHT; WEIGHT CHANGE; WILD TYPE; ANIMAL; BIOSYNTHESIS; BLOOD; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; PHARMACOLOGY;

BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; MURINAE; MUS;

ANIMALS; CITROBACTER RODENTIUM; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HYPERTENSION; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; SODIUM, DIETARY;

EID: 84902546348     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9809-6     Document Type: Article

References (35)

1. Hardwick, J.P. 2008. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochemical Pharmacology 75: 2263-2275.
2. Johnson, E.F., C.N. Palmer, K.J. Griffin, and M.H. Hsu. 1996. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB Journal 10: 1241-1248. (Pubitemid 26307509)
3. Sanders, R.J., R. Ofman, F. Valianpour, S. Kemp, and R.J. Wanders. 2005. Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes. Journal of Lipid Research 46: 1001-1008.
4. Gainer, J.V., A. Bellamine, E.P. Dawson, K.E. Womble, S.W. Grant, Y. Wang, L.A. Cupples, C.Y. Guo, S. Demissie, C.J. O'Donnell, N.J. Brown, M.R. Waterman, and J.H. Capdevila. 2005. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111: 63-69. (Pubitemid 40070845)
5. Heng, Y.M., C.S. Kuo, P.S. Jones, R. Savory, R.M. Schulz, S.R. Tomlinson, T.J. Gray, and D.R. Bell. 1997. A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochemical Journal 325(Pt 3): 741-749. (Pubitemid 27367766)
6. Powell, P.K., I. Wolf, R. Jin, and J.M. Lasker. 1998. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. Journal of Pharmacology and Experimental Therapeutics 285: 1327-1336. (Pubitemid 28277936)
7. Lasker, J.M., W.B. Chen, I. Wolf, B.P. Bloswick, P.D. Wilson, and P.K. Powell. 2000. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. Journal of Biological Chemistry 275: 4118-4126. (Pubitemid 30094644)
8. McGiff, J.C., and J. Quilley. 1999. 20-HETE and the kidney: resolution of old problems and new beginnings. American Journal of Physiology 277: R607-R623. (Pubitemid 29458131)
9. Miyata, N., and R.J. Roman. 2005. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. Journal of Smooth Muscle Research 41: 175-193. (Pubitemid 41596358)
10. Roman, R.J. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiological Reviews 82: 131-185. (Pubitemid 34654217)
11. Sarkis, A., and R.J. Roman. 2004. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Current Drug Metabolism 5: 245-256. (Pubitemid 38735779)
12. King, L.M., J.V. Gainer, G.L. David, D. Dai, J.A. Goldstein, N.J. Brown, and D.C. Zeldin. 2005. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenetics and Genomics 15: 7-13. (Pubitemid 43205521)
13. Liu, X., J.Wu, H. Liu, G. Lai, and Y. Zhao. 2012. Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice. Gene 505: 352-359.
14. Athirakul, K., J.A. Bradbury, J.P. Graves, L.M. DeGraff, J. Ma, Y. Zhao, J.F. Couse, R. Quigley, D.R. Harder, X. Zhao, J.D. Imig, T.L. Pedersen, J.W. Newman, B.D. Hammock, A.J. Conley, K.S. Korach, T.M. Coffman, and D.C. Zeldin. 2008. Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB Journal 22: 4096-4108.
15. Holla, V.R., F. Adas, J.D. Imig, X. Zhao, E. Price Jr., N. Olsen, W.J. Kovacs, M.A. Magnuson, D.S. Keeney, M.D. Breyer, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2001. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proceedings of the National Academy of Sciences of the United States of America 98: 5211-5216. (Pubitemid 32397108)
16. Nakagawa, K., V.R. Holla, Y. Wei, W.H. Wang, A. Gatica, S. Wei, S. Mei, C.M. Miller, D.R. Cha, E. Price Jr., R. Zent, A. Pozzi, M.D. Breyer, Y. Guan, J.R. Falck, M.R. Waterman, and J.H. Capdevila. 2006. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. Journal of Clinical Investigation 116: 1696-1702.
17. Chaluvadi, M.R., R.D. Kinloch, B.A. Nyagode, T.A. Richardson, M.J. Raynor, M. Sherman, L. Antonovic, H.W. Strobel, D.L. Dillehay, and E.T. Morgan. 2009. Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of Citrobacter rodentium. Drug Metabolism and Disposition 37: 366-374.
18. Nyagode, B.A., C.M. Lee, and E.T. Morgan. 2010. Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice. Journal of Pharmacology and Experimental Therapeutics 335: 480-488.
19. Richardson, T.A., M. Sherman, L. Antonovic, S.S. Kardar, H.W. Strobel, D. Kalman, and E.T. Morgan. 2006. Hepatic and renal cytochrome p450 gene regulation during Citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metabolism and Disposition 34: 354-360. (Pubitemid 43290892)
20. Richardson, T.A., and E.T. Morgan. 2005. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. Journal of Pharmacology and Experimental Therapeutics 314: 703-709. (Pubitemid 41043852)
21. Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
22. Quigley, R., S. Chakravarty, X. Zhao, J.D. Imig, and J.H. Capdevila. 2009. Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockoutmice. Nephron. Physiology 113: 23-28.
23. Cray, C., J. Zaias, and N.H. Altman. 2009. Acute phase response in animals: a review. Comparative Medicine 59: 517-526.
24. Murata, H., N. Shimada, and M. Yoshioka. 2004. Current research on acute phase proteins in veterinary diagnosis: an overview. Veterinary Journal 168: 28-40. (Pubitemid 38684202)
25. Kinloch, R.D., C.M. Lee, N. van Rooijen, and E.T. Morgan. 2011. Selective role for tumor necrosis factor-alpha, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen. Biochemical Pharmacology 82: 312-321.
26. Tunctan, B., B. Korkmaz, A.N. Sari, M. Kacan, D. Unsal, M.S. Serin, C.K. Buharalioglu, S. Sahan-Firat, T. Cuez, W.H. Schunck, J.R. Falck, and K.U. Malik. 2013. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKbeta/IkappaB-alpha/NF-kappaB pathway, and proinflammatory cytokine formation. Prostaglandins and Other Lipid Mediators 102-103: 31-41.
27. Ng, V.Y., Y. Huang, L.M. Reddy, J.R. Falck, E.T. Lin, and D.L. Kroetz. 2007. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metabolism and Disposition 35: 1126-1134. (Pubitemid 46956433)
28. Delerive, P., K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. Gonzalez, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels. 1999. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. Journal of Biological Chemistry 274: 32048-32054.
29. Muller, D.N., C. Schmidt, E. Barbosa-Sicard, M. Wellner, V. Gross, H. Hercule, M. Markovic, H. Honeck, F.C. Luft, and W.H. Schunck. 2007. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochemical Journal 403: 109-118. (Pubitemid 46569872)
30. Dierks, E.A., S.C. Davis, and P.R. Ortiz deMontellano. 1998. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole. Biochemistry 37: 1839-1847. (Pubitemid 28099806)
31. Xu, Z., L. Chen, L. Leung, T.S. Yen, C. Lee, and J.Y. Chan. 2005. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proceedings of the National Academy of Sciences of the United States of America 102: 4120-4125. (Pubitemid 40388565)
32. Christmas, P., K. Tolentino, V. Primo, K.Z. Berry, R.C. Murphy, M. Chen, D.M. Lee, and R.J. Soberman. 2006. Cytochrome P-450 4F18 is the leukotriene B4 omega-1/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4. Journal of Biological Chemistry 281: 7189-7196. (Pubitemid 43847485)
33. Lee, S.S., T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular and Cellular Biology 15: 3012-3022.
34. Barclay, T.B., J.M. Peters, M.B. Sewer, L. Ferrari, F.J. Gonzalez, and E.T. Morgan. 1999. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. Journal of Pharmacology and Experimental Therapeutics 290: 1250-1257. (Pubitemid 29400267)
35. Pan, J., Q. Xiang, S. Ball, J. Scatina, J. Kao, and J.Y. Hong. 2003. Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice. Drug Metabolism and Disposition 31: 392-397. (Pubitemid 36378516)